Anti-NMDA receptor encephalitis historical perspective: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Anti-NMDA receptor encephalitis}} {{CMG}} ==Overview== ==Historical Perspective== ==References== {{Reflist|2}} Category:Needs content Category:Rheumatolog...")
 
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Anti-NMDA receptor encephalitis}}
{{Anti-NMDA receptor encephalitis}}
{{CMG}}
{{CMG}}; AE {{DMakkar}}


==Overview==
==Overview==
Anti-NMDA encephalitis, first described in a 1830 case report, is an autoimmune disorder characterized by neurological and psychiatric symptoms. Ovarian teratoma is sometimes associated. Public awareness increased with Susannah Cahalan's case.


==Historical Perspective==
==Historical Perspective==
In the year 1830, a case report published in top medical journals in Hungarian, German, and Italian medical journals which can be traced back to as anti NMDA encephalitis associated with ovarian teratoma.
*A healthy 18-year-old woman experienced epileptic seizures, followed by six days of catalepsy, unresponsiveness, immobility, and shallow breathing. Her symptoms resurfaced frequently over the next 1.5 years. An ovarian tumor was diagnosed and removed leading to resolution of symptoms.
*In 2007 by Dalmau and Bataller, documented Anti-NMDA receptor encephalitis for the first time and demonstrated antibodies to a subunit of the NMDA glutamate receptor in patients with the condition neuropsychiatric manifestations.
The Susannah Cahalan case is a famous case of Anti NMDA Encephalitis and with publication of Brain on Fire—My Month of Madness in 2012 by New York Post reporter Susannah Cahalan, public awareness of this disorder rose. She described a quick progression from prodromal upper respiratory symptoms like a virus to acute psychosis which was confirmed with biopsy of her brain. She later recovered and continued her job.


==References==
==References==
Line 12: Line 20:
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Disease]]
[[Category:Disease]]
 
<ref name="pmid18851928">{{cite journal| author=Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M | display-authors=etal| title=Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. | journal=Lancet Neurol | year= 2008 | volume= 7 | issue= 12 | pages= 1091-8 | pmid=18851928 | doi=10.1016/S1474-4422(08)70224-2 | pmc=2607118 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18851928  }} </ref>
{{WH}}
<ref name="pmid23927937">{{cite journal| author=Merwick A, Dalmau J, Delanty N| title=Insights into antibody-associated encephalitis--Bickerstaff's 1950's papers revisited. | journal=J Neurol Sci | year= 2013 | volume= 334 | issue= 1-2 | pages= 167-8 | pmid=23927937 | doi=10.1016/j.jns.2013.07.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23927937  }} </ref>
{{WS}}

Latest revision as of 13:41, 13 May 2023

Anti-NMDA receptor encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anti-NMDA receptor encephalitis from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anti-NMDA receptor encephalitis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anti-NMDA receptor encephalitis historical perspective

CDC on Anti-NMDA receptor encephalitis historical perspective

Anti-NMDA receptor encephalitis historical perspective in the news

Blogs on Anti-NMDA receptor encephalitis historical perspective

Directions to Hospitals Treating Anti-NMDA receptor encephalitis

Risk calculators and risk factors for Anti-NMDA receptor encephalitis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; AE Dheeraj Makkar, M.D.[2]

Overview

Anti-NMDA encephalitis, first described in a 1830 case report, is an autoimmune disorder characterized by neurological and psychiatric symptoms. Ovarian teratoma is sometimes associated. Public awareness increased with Susannah Cahalan's case.

Historical Perspective

In the year 1830, a case report published in top medical journals in Hungarian, German, and Italian medical journals which can be traced back to as anti NMDA encephalitis associated with ovarian teratoma.

  • A healthy 18-year-old woman experienced epileptic seizures, followed by six days of catalepsy, unresponsiveness, immobility, and shallow breathing. Her symptoms resurfaced frequently over the next 1.5 years. An ovarian tumor was diagnosed and removed leading to resolution of symptoms.
  • In 2007 by Dalmau and Bataller, documented Anti-NMDA receptor encephalitis for the first time and demonstrated antibodies to a subunit of the NMDA glutamate receptor in patients with the condition neuropsychiatric manifestations.

The Susannah Cahalan case is a famous case of Anti NMDA Encephalitis and with publication of Brain on Fire—My Month of Madness in 2012 by New York Post reporter Susannah Cahalan, public awareness of this disorder rose. She described a quick progression from prodromal upper respiratory symptoms like a virus to acute psychosis which was confirmed with biopsy of her brain. She later recovered and continued her job.

References

[1] [2]

  1. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M; et al. (2008). "Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies". Lancet Neurol. 7 (12): 1091–8. doi:10.1016/S1474-4422(08)70224-2. PMC 2607118. PMID 18851928.
  2. Merwick A, Dalmau J, Delanty N (2013). "Insights into antibody-associated encephalitis--Bickerstaff's 1950's papers revisited". J Neurol Sci. 334 (1–2): 167–8. doi:10.1016/j.jns.2013.07.010. PMID 23927937.